Patent · US Active

Isoprene production using the DXP and MVA pathway

US8507235B2 · kind B2 · utility

7Cited by
17References
16Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 16, 2010
Grant dateAug 13, 2013
Priority date
Expiry dateJul 30, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/70
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides for methods for producing isoprene from cultured cells using various components of the DXP pathway and MVA pathway, or components associated with the DXP pathway and MVA pathway, iron-sulfur cluster-interacting redox polypeptides, and isoprene synthase. The invention also provides compositions that include these cultured cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.